Skip to search boxSkip to navigationSkip to main content

Monkeypox viral detection in semen specimens of confirmed cases: A systematic review and meta-analysis

  • Abdullah Reda
    ,
  • Abdelaziz Abdelaal
    ,
  • Aml M. Brakat
    ,
  • Basant Ismail Lashin
    ,
  • Moustafa Abouelkheir
    ,
  • Basel Abdelazeem
*Corresponding author for this work
  • Al-Azhar University, Faculty of Medicine
    ,
  • Tanta Research Team
    ,
  • Faculty of Medicine
    ,
  • Harvard Medical School
    ,
  • Zagazig University, Faculty of Medicine
    ,
  • Faculty of Medicine
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

e28250

Journal (Volume, Issue Number)

Journal of Medical Virology (Volume 95, Issue 1)

Publication milestones

  • Published - 01/2023

Publication status

Published - 01/2023

ISSN

0146-6615

Publication IDs

  • Scopus: 85141365362
  • PubMed: 36271741

Abstract

The current literature shows increasing concerns about potential seminal transmission of monkeypox virus (MPXV). Accordingly, we aimed to understand better the potential presence of MPXV in the seminal fluids and others specimens obtained from MPX cases. On June 26, 2022, a systematic search of the literature was conducted to find articles that examine the presence of MPXV in the seminal fluid of confirmed cases. The search was updated once on August 12 and another on October 12, 2022, to include newly published articles. The prevalence of MPXV DNA presence in the seminal fluid and other specimens was pooled in a meta-analysis (from studies with sample size > 5 to reduce overestimation) and results were presented as effect sizes (ES) and their corresponding 95% confidence intervals (CI). Nine articles were included. Only five studies were eligible for a meta-analysis, and the pooled prevalence of MPXV DNA in semen specimens was 72.4% (95% CI: 55.7%−84.5%) among 115 patients. The positive rate of MPXV viral polymerase chain reaction (PCR) was higher among skin samples (89%; 95% CI: 78.2%−94.8%; N = 62; studies = 2), followed by anogenital/rectal samples (74.3%; 95% CI: 60.4%−84.5%; N = 54; studies = 2). On the other hand, the positivity rate was lower in nasopharyngeal (62.4%; 95% CI: 20.4%−91.5%; N = 587; studies = 3), urine (21.1%; 95% CI: 4.3%−61.1%; N = 617; studies = 4), and blood/plasma (14.3%; 95% CI: 11.3%−18.1%; N = 609; studies = 3) samples. Besides, MPXV can be detected in semen early from Day 1 and up to 19 days after symptoms onset. Finally, two articles investigated the infectivity of MPXV particles detected in seminal specimens by testing their replication competence. Culturing MPXV was successful in two out of four patients included in these studies. MPXV is highly prevalent in seminal specimens of MPX cases, further corroborating the role of sexual transmission of the disease. However, further evidence is still needed to shed more light on the replication competence of these particles.

Publication metrics

Metrics

Scopus
Citations

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well